{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:33:12Z","timestamp":1791167592488,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Biotechnology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.tibtech.2004.06.008","type":"journal-article","created":{"date-parts":[[2004,7,6]],"date-time":"2004-07-06T20:54:52Z","timestamp":1089147292000},"page":"423-427","source":"Crossref","is-referenced-by-count":70,"title":["Design and development of oral drugs for the prophylaxis and treatment of smallpox infection"],"prefix":"10.1016","volume":"22","author":[{"given":"George R.","family":"Painter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Y.","family":"Hostetler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibtech.2004.06.008_BIB1","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1001\/jama.281.22.2127","article-title":"Smallpox as a biological weapon: medical and public health management","volume":"281","author":"Henderson","year":"1999","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB2","unstructured":"Gellman, B. (2002) Four nations thought to possess smallpox. Washington Post, 4 November, Section A, p. 1."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB3","unstructured":"Altman, L.K. (2002) Close monitoring is planned for smallpox vaccinations. New York Times, 18 October, p. 11."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1128\/JVI.75.3.1205-1210.2001","article-title":"Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox","volume":"75","author":"Jackson","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-126-4-199702150-00002","article-title":"Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS","volume":"126","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1086\/315190","article-title":"Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge","volume":"181","author":"Bray","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003088-199936020-00004","article-title":"Clinical pharmacokinetics of the antiviral nucleotide analogs cidofovir and adefovir","volume":"36","author":"Cundy","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB8","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0006-2952(97)82446-X","article-title":"Enhanced oral absorption and antiviral activity of 1-0-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro","volume":"53","author":"Hostetler","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/15257770008033022","article-title":"Synthesis and antiviral evaluation of 1-0-hexadecylpropanediol-3-P-acyclovir: efficacy against HSV-1 infection in mice","volume":"19","author":"Beadle","year":"2000","journal-title":"Nucleosides Nucleotides"},{"key":"10.1016\/j.tibtech.2004.06.008_BIB10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/AAC.46.4.991-995.2002","article-title":"Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir","volume":"46","author":"Kern","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB11","doi-asserted-by":"crossref","unstructured":"B\u00f6rgstrom, B. (1974) Biomembranes (Vol. 4b) (Smyth, D.H., ed.), pp. 555\u2013620, Plenum Press.","DOI":"10.1007\/978-1-4684-3336-4_1"},{"key":"10.1016\/j.tibtech.2004.06.008_BIB12","doi-asserted-by":"crossref","first-page":"25337","DOI":"10.1074\/jbc.M203809200","article-title":"Transbilayer movement of dipalmitoylphosphatidylcholine in proteoliposomes reconstituted from detergent extracts of endoplasmic reticulum","volume":"277","author":"Gummad","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB13","doi-asserted-by":"crossref","first-page":"16495","DOI":"10.1016\/S0021-9258(18)49283-6","article-title":"Assembly of the endoplasmic reticulum phospholipid bilayer","volume":"262","author":"Kawashima","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.ph.49.030187.001205","article-title":"Intracellular lipid transport in eukaryotes","volume":"49","author":"Sleight","year":"1978","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB15","unstructured":"Simmonds, W.J. (1972) Blood Lipids and Lipoproteins: Quantitation, Composition and Metabolism (Nelson, G.J., ed.), pp. 705\u2013743, Wiley-Interscience."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/BF02535644","article-title":"Absorption and transport of fat in mammals with emphasis on n-3 polyunsaturated fatty acids","volume":"23","author":"Nelson","year":"1988","journal-title":"Lipids"},{"key":"10.1016\/j.tibtech.2004.06.008_BIB17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0166-3542(03)00110-4","article-title":"Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney","volume":"59","author":"Ciesla","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB18","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/0006-2952(93)90670-R","article-title":"Mechanism of uptake of the phosphonate analog (s)-1-(3-hydroxy-2-phosphonylmethoxy-propyl) cytosine (HPMPC) in Vero cells","volume":"46","author":"Connelly","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1128\/JVI.13.2.488-493.1974","article-title":"Vaccinia virus replication in enucleated BSC-1 cells: particle production and synthesis of viral DNA and proteins","volume":"13","author":"Pennington","year":"1974","journal-title":"J. Virol."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB20","first-page":"197","article-title":"Intracellular metabolism of the anti-herpes agent (s)-1-[3-hydroxy-2-(phosphonyl-methoxy)propyl] cytosine","volume":"41","author":"Ho","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1124\/mol.63.3.678","article-title":"Increased antiviral activity of 1-0-hexadecyloxypropyl-[2-14C] cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism","volume":"63","author":"Aldern","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB22","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.virol.2003.11.015","article-title":"Efficacy of orally active ether lipid analogs of cidofovir in a lethal mousepox model","volume":"318","author":"Buller","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.tibtech.2004.06.008_BIB23","first-page":"104","article-title":"Orally active ether lipid prodrugs of cidofovir for the treatment of smallpox","volume":"53","author":"Huggins","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-3542(02)00199-7","article-title":"A review of compounds exhibiting anti-orthopoxvirus activity in animal models","volume":"57","author":"Smee","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.tibtech.2004.06.008_BIB25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1128\/AAC.48.2.404-412.2004","article-title":"Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir","volume":"48","author":"Quenelle","year":"2004","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Trends in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779904001738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779904001738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T01:39:57Z","timestamp":1624498797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167779904001738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0167779904001738"],"URL":"https:\/\/doi.org\/10.1016\/j.tibtech.2004.06.008","relation":{},"ISSN":["0167-7799"],"issn-type":[{"value":"0167-7799","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}